IRIS
CORDERA, RENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.932
AS - Asia 97
SA - Sud America 18
NA - Nord America 3
Totale 20.050
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.931
CN - Cina 73
SG - Singapore 20
BR - Brasile 17
VN - Vietnam 4
US - Stati Uniti d'America 3
PY - Paraguay 1
RU - Federazione Russa 1
Totale 20.050
Salva come PNG Salva come JPEG
Città #
Genova 12.652
Genoa 4.255
Rapallo 1.764
Vado Ligure 1.239
Beijing 34
Bordighera 21
Ashburn 3
Singapore 3
São Paulo 2
Bom Conselho 1
Borda da Mata 1
Bắc Giang 1
Bắc Ninh 1
Can Tho 1
Curitiba 1
Guanambi 1
Hanoi 1
Irecê 1
Itatiba 1
Itá 1
Macapá 1
Manaus 1
Montes Claros 1
Ribeirão das Neves 1
Rio de Janeiro 1
Rostov-on-Don 1
Salvador 1
Santo André 1
São Gabriel do Oeste 1
São João de Meriti 1
Totale 19.994
Salva come PNG Salva come JPEG
Nome #
IGF1 regulates PKM2 function through Akt phosphorylation 227
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 214
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 209
Effect of two fasting periods of different duration on ghrelin response to a mixed meal. 198
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 197
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 197
IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells. 195
Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of Hexokinase-II 192
Biliopancreatic diversion 190
Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. 182
Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion 182
Adipose Tissue Composition in Obesity and After Bariatric Surgery 179
Caveolin-1 is essential for Metformin inhibitory effect on IGF1 action in non-small cell lung cancer cells 177
Antipeptide antibodies toward the extracellular domain of insulin receptor beta-subunit. 174
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 171
Switching from Glargine to Degludec is not associated with an overt change in glucose control in a cohort of patients with type 1 diabetes: a CGM analysis 170
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 168
Alexithymia and eating behaviour in severely obese patients. 166
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 166
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts. 165
Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1–36) following low doses of a whey protein-rich nutraceutic 163
The interplay between diabetes, depression and affective temperaments: A structural equation model 162
Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors 161
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 159
Influence of cell age and ketoaminic linkage on rapid glycosylation of hemoglobin in human red cells in vitro. 157
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss. 156
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 154
Glucose-targeted therapy for subjects with Type 2 Diabetes Mellitus: "Primum non nocere" 153
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 153
Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies. 152
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 151
Serum Leptin and Adiponectin Concentration in Type 2 Diabetes Patients in the Short and Long Term Following Biliopancreatic Diversion. 150
Data-driven strategies for robust forecast of continuous glucose monitoring time-series 149
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 147
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149 146
IGF-I induced rapid recruitment of integrin β1 to lipid rafts is Caveolin-1 dependent 146
Effect of two different glucose concentrations on insulin receptor mRNA levels in human hepatoma HepG2 cells. 143
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 142
INSULIN ANALOGUES: FEARS, FACTS AND FANTASIES 137
Toxic thyroid adenoma: absence of DNA mutations of the TSH receptor and Gs alpha 137
The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30-35 kg/m2) and Simple Overweight (BMI 25-30 kg/m 2) A Prospective Controlled Study. 137
Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. 136
Species specificity of insulin binding and insulin receptor protein tyrosine kinase activity. 136
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 136
Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 136
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently) 136
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 135
Association between plasma insulin and angiographically documented significant coronary artery disease. 135
A method for erythrocyte filtration. 135
I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. 135
Effects of Gastric Bypass on Type 2. Diabetes in Patients with BMI 30 to 35 134
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 134
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 134
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells 133
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects. 132
Effect of insulin receptor autophosphorylation on insulin receptor binding. 132
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. 132
Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. 131
Inhibition of insulin and epidermal growth factor (EGF) receptor autophosphorylation by a human polyclonal IgG. 130
Short-term liver function after biliopancreatic diversion. 130
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts 129
Energy and nitrogen absorption after biliopancreatic diversion 129
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 129
Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. 129
Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. 128
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 128
Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity 128
Substrate specificities of insulin and epidermal growth factor receptor kinases. 127
Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. 127
Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent 126
Role of IRS-1 and SHC activation in 3T3-L1 fibroblasts differentiation. 126
IGF-I regulates caveolin 1 and IRS1 interaction in caveolae 126
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes. 125
Regulation of insulin receptor-associated tyrosine kinase by a polyclonal IgG. 125
Insulin binding on MOLT 4 cells: effect of a sulfonylurea. 124
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 123
Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica. 123
HOMA, BMI, and serum leptin levels variations during antiviral treatment suggest virus-related insulin resistance in noncirrhotic, nonobese, and nondiabetic chronic hepatitis C genotype 1 patients 122
Absence of 619 mutation in the TSH receptor in 7 toxic adenoma 121
Effects of dietary restriction on serum leptin concentration in obese women. 120
Increased phosphorylation of ribosomal protein S6 following microinjection of insulin receptor-kinase into Xenopus oocytes. 118
High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. 118
Pregnancies in an 18-year follow-up after biliopancreatic diversion 118
From bariatric to metabolic surgery: Looking for a "disease modifier" surgery for type 2 diabetes. 118
Porcine and human semisynthetic insulin bind equally to the insulin receptor on red blood cells. 117
CLINICAL STUDY: Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. 116
[Psychological aspects in the therapy of diabetes]. 116
Bariatric or Metabolic Surgery? 116
Insulin receptor regulation in human mature red cells in vitro. 115
Serum levels of osteopontin predict diabetes remission after bariatric surgery 115
IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts 114
Short-term changes in serum leptin concentration following biliopancreatic diversion 114
Association of body mass index, physical activity and eating pattern in adult men 114
absence of 619 mutation in the TSH receptor in seven toxic adenomas 114
Plasma ghrelin concentratin in the short-term following biliopancreaticdiversion. 114
Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling. 114
high molecular weight adiponectin isoforms increase after bilopancreati diversion in obese subjects 113
A ser for Cys mutation in the extracellular portion of insulin receptor beta subunit impairs the insulin-insulin receptor complex internalization in CHO cells. 112
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. 112
Caveolin-1 is essential for glimepiride-induced insulin secretion in the pancreatic betaTC-6 cell line 111
Totale 14.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.578
article - articoli 57.089
book - libri 0
conference - conferenze 3.264
curatela - curatele 0
other - altro 338
patent - brevetti 0
selected - selezionate 0
volume - volumi 887
Totale 123.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021993 0 0 0 110 100 94 87 107 147 139 104 105
2021/20222.137 55 116 126 318 96 179 141 444 96 211 61 294
2022/20232.073 184 133 31 199 375 377 3 194 364 8 178 27
2023/2024935 38 143 14 116 61 141 59 36 62 34 80 151
2024/20253.015 114 206 90 196 472 288 249 467 115 109 312 397
2025/20261.378 653 94 260 371 0 0 0 0 0 0 0 0
Totale 20.229